Novoeight HCP Email: “See a Comparison Chart”
Received: Oct 4, 2018 at 12:01 PM Subject: 1 alternative to Helixate® FS: Novoeight® (Antihemophilic Factor [Recombinant]). From: Novo Nordisk
Received: Oct 4, 2018 at 12:01 PM Subject: 1 alternative to Helixate® FS: Novoeight® (Antihemophilic Factor [Recombinant]). From: Novo Nordisk
From: ACADIA Pharmaceuticals Inc. Sent on: Jan 21, 2019 Subject line: You signed up to learn more. We’re happy to help Preheader: Please see Important Safety Information including Boxed WARNING at the bottom of this email.
Screenshot taken on Jan 15, 2019.
Screenshot taken on Jan 15, 2019.